R. Naeije (Brussels, Belgium), S. Adnot (Creteil, France)
Incomplete gas-exchange resolution after liver transplantation in hepatopulmonary syndrome
F. P. Gómez, G. Martinez-Pallí, J. C. García-Valdecasas, J. A. Barberà, J. Roca, R. Rodriguez-Roisin (Barcelona, Spain)
|   |
Endothelin-1 in patients with the hepatopulmonary syndrome
P. Schenk, V. Fuhrmann, M. Schoeniger-Hekele, C. Mueller, O. F. Wagner (Vienna, Austria)
| |
Hepatopulmonary syndrome is associated with bacterial translocation in cirrhotic rats
B. Sztrymf, D. Lebrec, M. Mazmanian, P. Herve (Le Plessis Robinson, Clichy, France)
| |
Overexpression of serotonin receptor 1B (5HT-1B) responsible for overflow induced experimental pulmonary arterial hypertension development
B. Rondelet, F. Kerbaul, S. Motte, R. Van Beneden, K. Jean-Marie, R. Naeije (Brussels, Belgium)
| |
Expression of endothelial nitric oxide synthase (eNOS) and endothelin-1 (ET-1) in pulmonary arteries of patients with severe COPD
T. Melgosa, V. Peinado, S. Santos, J. Morales, J. Ramirez, J. Roca, R. Rodriguez-Roisin, J. Barbera (Barcelona, Spain)
| |
Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive lung disease
S. Eddahibi, A. Chaouat, N. Morrell, E. Fadel, C. Fuhrman, P. Dartevelle, B. Housset, M. Hamon, E. Weitzenblum, S. Adnot (Créteil, France)
| |
Model-based combination of pressure and flow: a framework for differential diagnosis of pulmonary hypertension
J. W. Lankhaar, T. J. Faes, R. J. Roeleveld, J. T. Marcus, N. Westerhof, A. Vonk Noordegraaf (Amsterdam, The Netherlands)
| |
Effects of iloprost and the phosphodiesterase inhibitor tolafentrine on pulmonary vascular remodelling in chronic experimental pulmonary hypertension
R. T. Schermuly, K. P. Kreisselmeier, A. Ghofrani, N. Weissmann, F. Rose, C. Schudt, W. Seeger, F. Grimminger (Giessen, Konstanz, Germany)
| |